Department of Ophthalmology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Department of Ophthalmology, Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.
Am J Case Rep. 2021 Jun 16;22:e930467. doi: 10.12659/AJCR.930467.
BACKGROUND Herpes simplex virus (HSV) stromal keratitis with ulceration is one of the most serious forms of herpes corneal infection and is one of the most difficult conditions in terms of clinical management. We assessed the efficacy of intravenous acyclovir in the treatment of this condition. CASE REPORT Two cases of HSV stromal keratitis with ulceration were reported in terms of clinical presentation, investigation, treatment, and outcome.Diagnosis was confirmed by polymerase chain reaction (PCR) analysis. PCR testing of corneal scraping samples identified HSV-1 in the first patient and HSV-2 in the second patient. The first patient initially presented with herpes geographic epithelial keratitis and progressed to HSV stromal keratitis with ulceration during treatment with a prophylactic dose of oral acyclovir. Despite oral acyclovir therapy, the cornea lesion continued to worsen. The treatment was switched to intravenous acyclovir. The stromal infiltration gradually improved, and the epithelial defect closed. The second patient, who had undergone penetrating keratoplasty for 13 years, presented with extensive corneal infiltration and corneal melting. The laboratory work-up was positive for HSV-2, and intravenous acyclovir was prescribed. The patient's corneal infiltration improved, but a persistent epithelial defect was present. Then, 100% autologous serum was used until the epithelial defect closed. Prophylactic treatment with oral acyclovir was prescribed to both patients to prevent disease recurrence. CONCLUSIONS Intravenous acyclovir might be considered as an alternative treatment for patients with HSV stromal keratitis with ulceration who do not respond to oral acyclovir or those with an extensive infection on a corneal graft.
单纯疱疹病毒(HSV)基质性角膜炎伴溃疡是最严重的疱疹性角膜感染形式之一,也是临床管理中最困难的情况之一。我们评估了静脉用阿昔洛韦治疗这种疾病的疗效。
报告了两例 HSV 基质性角膜炎伴溃疡的病例,包括临床表现、检查、治疗和结果。诊断通过聚合酶链反应(PCR)分析得到确认。对角膜刮片样本的 PCR 检测在第一例患者中鉴定出 HSV-1,在第二例患者中鉴定出 HSV-2。第一例患者最初表现为疱疹性地图状上皮角膜炎,在口服阿昔洛韦预防性剂量治疗期间进展为 HSV 基质性角膜炎伴溃疡。尽管进行了口服阿昔洛韦治疗,角膜病变仍继续恶化。治疗方案改为静脉用阿昔洛韦。基质浸润逐渐改善,上皮缺损闭合。第二位患者曾接受穿透性角膜移植术 13 年,表现为广泛的角膜浸润和角膜融解。实验室检查结果为 HSV-2 阳性,并开具了静脉用阿昔洛韦。患者的角膜浸润改善,但仍存在持续性上皮缺损。随后,使用 100%自体血清,直至上皮缺损闭合。给两位患者开具了口服阿昔洛韦预防性治疗,以预防疾病复发。
对于口服阿昔洛韦治疗无效或角膜移植后感染广泛的 HSV 基质性角膜炎伴溃疡患者,静脉用阿昔洛韦可能是一种替代治疗方法。